Publications dans lesquelles il/elle collabore avec SANDRA BLANCO BENAVENTE (20)

2024

  1. The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues

    NAR Cancer, Vol. 6, Núm. 1

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  2. N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer

    Oncogene, Vol. 42, Núm. 43, pp. 3169-3181

2022

  1. Epigenetic and Epitranscriptomic Control in Prostate Cancer

    Genes, Vol. 13, Núm. 2

2014

  1. Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response

    Oncotarget, Vol. 5, Núm. 7, pp. 1770-1778

2013

  1. Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression

    Cell Death and Disease, Vol. 4, Núm. 2

2012

  1. VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling

    Cellular and Molecular Life Sciences, Vol. 69, Núm. 22, pp. 3881-3893

2010

  1. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer

    Molecular and Cellular Biology, Vol. 30, Núm. 19, pp. 4687-4697

2009

  1. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

    Human Molecular Genetics, Vol. 18, Núm. 7, pp. 1343-1352

2008

  1. Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein

    PLoS ONE, Vol. 3, Núm. 2

  2. The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas

    Lung Cancer, Vol. 58, Núm. 3, pp. 303-309

  2. Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

    Archives of Biochemistry and Biophysics, Vol. 465, Núm. 1, pp. 219-226

  3. Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1

    Molecular and Cellular Biology, Vol. 27, Núm. 20, pp. 7273-7283

2006

  1. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines

    FEBS Journal, Vol. 273, Núm. 11, pp. 2487-2504

  2. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma

    Molecular Cancer Research, Vol. 4, Núm. 3, pp. 177-185

  3. Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling

    Journal of Virology, Vol. 80, Núm. 15, pp. 7667-7675

  4. p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop

    Molecular and Cellular Biology, Vol. 26, Núm. 13, pp. 4782-4793

2004

  1. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism

    Virology, Vol. 328, Núm. 2, pp. 254-265

2003

  1. Human TSG101 does not replace Saccharomyces cerevisiae VPS23 role in the quality control of plasma membrane proteins

    FEMS Microbiology Letters, Vol. 221, Núm. 2, pp. 151-154